Predictores epigenéticos e inmunológicos de respuesta a fármacos biológicos en la Enfermedad Inflamatoria Intestinal (EII). Herramientas para la medicina personalizada y de precisión en la EII.

Datos básicos

Protocolo:: 2022-557-1_EOm
EUDRACT:
NCT:
Centro:: HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
Año de incio:: 2022
Año de finalización:

ESTUDIO OBSERVACIONAL

Documentos

No hay documentos

Participantes

Inés Moret Tatay

Investigador Principal

Grupos

Enfermedad Inflamatoria Intestinal

Leader

Pilar Nos Mateu

Financiadores - Promotores

INÉS MORET TATAY

Resultados del Ensayo Clínico

Publicaciones en Revistas 6

Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn's disease.

Moret-Tatay, Ines; (...); Beltran, Belen

Article. 10.1093/cei/uxad134. 2024

Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review.

Plaza J; (...); Moret-Tatay I

Article. 10.3390/ijms25073717. 2024

Human umbilical cord platelet-rich plasma to treat endometrial pathologies: methodology, composition and pre-clinical models.

Rodriguez-Eguren, Adolfo; (...); Cervello, Irene

Article. 10.1093/hropen/hoac053. 2023

Immunoepigenetic Regulation of Inflammatory Bowel Disease: Current Insights into Novel Epigenetic Modulations of the Systemic Immune Response.

Bastida, Guillermo; (...); Moret-Tatay, Ines

Article. 10.3390/genes14030554. 2023

MicroRNA and granulocyte-monocyte adsorption apheresis combotherapy after inadequate response to anti-TNF agents in ulcerative colitis.

Saez-Gonzalez, Esteban; (...); Beltran, Belen

Article. 10.1002/jca.22101. 2023

Therapeutic drug monitoring during induction therapy with Ustekinumab in patients with Crohn's disease: the key to early identification of patients with inadequate response

Minguez, A.; (...); Nos, P.

Meeting Abstract. 2023